700 patients110,866 observations180 daysLIVE

Patient P-02237

Synthetic patientMETA-24 · Day 139 · 35–44 · M · baseline S04Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
20%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S04

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Treatment adherence-12
  • GI instability-5
  • Nutritional resilience+5
  • Toxicity+2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    33 min
    stable · -0.9 vs previous 14 d
    Sleep duration
    Wearable
    8.1 h
    stable · -0.0 vs previous 14 d
    Energy level
    Daily log
    6.5/10
    worsening · -0.4 vs previous 14 d
    Steps
    Wearable
    3,298
    worsening · -206 vs previous 14 d
    GI burden
    Companion
    20/100
    worsening · +5.1 vs previous 14 d
    Adherence
    Companion
    87.2 %
    stable · -3.2 vs previous 14 d
    Sleep quality
    Wearable
    73.2/100
    stable · -0.2 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    135 mg/dL
    stable · +3.9 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 70 from the failing basin, 21 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +9.6
    • Butyrate producers intact
      hidden · steering +7.5
    • Caffeine (supports)
      perturbation · steering +5.4
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -5.1 next day
    • Caffeine
      supporter · GI -3 next day
    Main detractors to watch
    • Bacteroides fragilis elevated
      hidden · steering -7.4
    • IL6 high-expression variant
      hidden · steering -7.3
    • Ultra-processed food
      perturbation · steering -6.7
    • Antibiotic course
      perturbation · steering -4.7
    • Ultra-processed food
      detractor · GI +3.7 next day
    • Alcohol
      detractor · GI +2.5 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -5.1supporter · 95%
    • Ultra-processed food
      +3.7detractor · 95%
    • Caffeine
      -3supporter · 65%
    • Alcohol
      +2.5detractor · 64%
    • Histamine load
      +1.5no signal · 29%
    • Insoluble fibre
      +1.5no signal · 31%
    • Dietary fat load
      -0.6no signal · 15%
    • Simple carbohydrates
      +0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling 45
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
    • Autonomic recovery 45
      • WearableResting HR 72 bpm
      • Wearable3,298 steps/day
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 3.5 · butyrate capacity 78/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    61 ms
    Sleep
    7.6 h
    Steps
    2,637
    Resting HR
    74 bpm
    Daily log: GI score 20, nutritional resilience 67, adherence 87.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0203132%S12AD-05improved47
    P-0228532%S14AD-05no change39
    P-0248350%S06BR-03no change64
    P-0228035%S07BR-03no change50
    P-0208733%S01BR-03no change40
    P-0226733%S09BR-03no change45
    P-0252231%S01BR-03no change40
    P-0223331%S16CR-01improved66
    P-0235431%S01CR-01improved78
    P-0246244%S12DT-01improved65
    P-0249144%S09DT-01no change65
    P-0233939%S03DT-01improved50